CLYM
Climb Bio, Inc. Common Stock
stockNASDAQ
Market OpenOct 5, 2026 10:47:26 AM EDT
10.79USD-1.371%(-0.15)234,644
10.78Bid10.80Ask0.02SpreadPre-marketOct 5, 2026 9:10:30 AM EDT
10.95USD+0.091%(+0.01)
CLYM News
Climb Bio to present Phase 2 data on kidney disease therapies · 
Investing.com
The Biggest Losers In Biotech — And It Had Nothing To Do With 'Compelling,' 'Best-In-Disease' Data · 
Investor's Business Daily